Compare ROIV & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | KTOS |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 11.7B |
| IPO Year | N/A | 1999 |
| Metric | ROIV | KTOS |
|---|---|---|
| Price | $21.70 | $74.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $21.94 | ★ $79.71 |
| AVG Volume (30 Days) | ★ 6.7M | 2.1M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.23 |
| EPS | N/A | ★ 0.13 |
| Revenue | $20,329,000.00 | ★ $1,284,800,000.00 |
| Revenue This Year | N/A | $19.25 |
| Revenue Next Year | $376.94 | $20.15 |
| P/E Ratio | ★ N/A | $600.94 |
| Revenue Growth | N/A | ★ 14.00 |
| 52 Week Low | $8.73 | $23.90 |
| 52 Week High | $22.45 | $112.57 |
| Indicator | ROIV | KTOS |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 46.12 |
| Support Level | $20.14 | $73.20 |
| Resistance Level | $21.48 | $79.47 |
| Average True Range (ATR) | 0.71 | 3.64 |
| MACD | 0.00 | 0.60 |
| Stochastic Oscillator | 65.96 | 47.89 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.